Alleviation of cisplatin‐induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase‐3 activity
Pharmacology Research & Perspectives2021Vol. 9(3), pp. e00788–e00788
Citations Over TimeTop 10% of 2021 papers
Fatemeh Taghizadeh, Seyed Jalal Hosseinimehr, Mehryar Zargari, Abbasali Karimpour Malekshah, Mansoureh Mirzaei, Fereshteh Talebpour Amiri
Abstract
In conclusion, GLZ with its antioxidant, anti-inflammatory, and anti-apoptotic activities, can be suggested as a promising drug in the treatment of CP-induced hepatotoxicity.
Related Papers
- → Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles(2021)35 cited
- → Comparison of uptitration of gliclazide with the addition of rosiglitazone to gliclazide in patients with type 2 diabetes inadequately controlled on half-maximal doses of a sulphonylurea(2004)28 cited
- → Efficacy of gliclazide in comparison with other sulphonylureas in the treatment of NIDDM(1991)31 cited
- → Pharmacokinetics and hypoglycemic effect of gliclazide loaded in Isabgol husk mucilage microparticles(2021)6 cited
- → A Review on the Formulation and Analysis of Anti-Diabetic Agent: Gliclazide(2013)3 cited